SecurityGSK / GlaxoSmithKline plc
InstitutionVerition Fund Management LLC
Shares5,233
Value $ 211,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Verition Fund Management LLC ownership in GSK / GlaxoSmithKline plc

August 15, 2018 - Verition Fund Management LLC has filed a 13F-HR form disclosing ownership of 5,233 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $211,000 USD as of June 30, 2018. Verition Fund Management LLC had filed a previous 13F-HR on May 15, 2018 disclosing 0 shares of GlaxoSmithKline plc at a value of $0 USD.

Other investors with positions similar to Verition Fund Management LLC include Fox Run Management, L.l.c., First Citizens Bank & Trust Co, Birmingham Capital Management Co Inc/al, Chemical Bank, Integrated Wealth Concepts Llc, and Trustco Bank Corp N Y.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 5,233 211 211 0
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 -100.00 0 -100.00 0 0
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 16,996 603 603 0
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 -100.00 0 -100.00 0 0
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 30,141 1,300 1,300 0
2015-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 -100.00 0 -100.00 0 0
2015-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 4,861 202 202 0
2014-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 -100.00 0 -100.00 0 0
2014-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 5,580 257


CUSIP: 37733W105